In today’s Smart Money, I’ll explain how the hype surrounding the AI trade is diverting attention from potentially lucrative pharmaceutical stocks. And why that disconnect, along with several promising developments, could make now the right time to take another look at the sector.

Today, Tom Yeung will consider the dangers of the latest AI mania – and the safer investing path to follow instead.

In today’s Smart Money, I’ll explain how the hype surrounding the AI trade is diverting attention from potentially lucrative pharmaceutical stocks. And why that disconnect, along…